Fasting glucose improvement under dasatinib treatment in an accelerated phase chronic myeloid leukemia patient unresponsive to imatinib and nilotinib

Breccia, M., Muscaritoli, M., Cannella, L., Stefanizzi, C., Frustaci, A.M., &amp; Alimena, G. (2008). Fasting glucose improvement under dasatinib treatment in an accelerated phase chronic myeloid leukemia patient unresponsive to imatinib and nilotinib. <em>Leukemia Research</em>. https://doi.org/10.1016/j.leukres.2008.01.015

Breccia M, Muscaritoli M, Cannella L, Stefanizzi C, Frustaci AM, Alimena G. Fasting glucose improvement under dasatinib treatment in an accelerated phase chronic myeloid leukemia patient unresponsive to imatinib and nilotinib. Leukemia Research. 2008. doi:10.1016/j.leukres.2008.01.015.

@article{massimo2008Fastin, title = {Fasting glucose improvement under dasatinib treatment in an accelerated phase chronic myeloid leukemia patient unresponsive to imatinib and nilotinib}, author = {Massimo Breccia and Maurizio Muscaritoli and Laura Cannella and Caterina Stefanizzi and Anna Maria Frustaci and Giuliana Alimena}, journal = {Leukemia Research}, year = {2008}, doi = {10.1016/j.leukres.2008.01.015}, }